While there are many possible reasons for regulators to conduct an inspection during a clinical trial, most of the time, it's to verify these two things and to ensure that the research is being conducted according to the study protocol and GCP regulations.

This white paper, “FDA Inspections of Clinical Investigators: Are You Ready?,” offers the following tips: